India respiratory inhalers market is expected to grow at a significant CAGR during the forecast period, FY2023-FY2027. Increasing prevalence of respiratory diseases due to increasing pollution in the environment is the major factor driving the respiratory inhalers market. Rising disposable income among the middle class is increasing the expenditure capacity of consumers on availing quality healthcare services which is the contributing factor for the high demand for respiratory inhalers. Increase in the number of factories build up to cater the needs of rising population is expected to release high volumes of pollutants into the environment. Also, the expanding automotive sector is aiding in increased number of vehicles on the road which release carbon dioxide into the emission thereby contributing to air pollution in the region. Ability to cure the prevailing respiratory diseases of inhalers is fueling the growth of the market. Adoption of combination therapies for asthma and COPD is accelerating the demand for respiratory inhalers in the region. The accuracy in making doses in respiratory inhalers to cure combination of diseases is aiding in enhanced respiratory inhalers’ market demand. Respiratory inhalers are the most effective way to induce the drug into the body.

India respiratory inhalers market is segmented into product type, technology, disease indication, distribution channel, end user, region, and company. Based on product type, market is further divided into dry powder inhaler, metered dose inhaler and others. Dry powder inhaler segment is expected to account for major market share during the forecast period. It offers precision in curing the respiratory problems and can be used easily which are the major factors fostering the respiratory inhalers market. Dry powder inhalers are compact and portable in nature and the co-ordination for patients for inducing dosage is not mandatory.

The major players operating in the India respiratory inhalers market are Philips India Limited, Cipla Limited, Teva API India Limited, Astra Zeneca Pharma India Limited, GlaxoSmithKline Pharmaceuticals Ltd, Omron Healthcare India Pvt. Ltd., Novartis India Ltd., 3M India ltd, Glenmark Pharmaceuticals Limited, Merck India, and others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.

Years considered for this report:

Historical Years: FY2017-FY2020

Base Year: FY2021

Estimated Year: FY2022

Forecast Period: FY2023-FY2027

Objective of the Study:

  • To analyze the historical growth in the market size of India respiratory inhalers market from FY2017 to FY2020.
  • To estimate and forecast the market size of India respiratory inhalers market from FY2021 to FY2027 and growth rate until FY2027.
  • To classify and forecast India respiratory inhalers market based on product type, technology, disease indication, distribution channel, end user, regional distribution, and company.
  • To identify dominant region or segment in the India respiratory inhalers market
  • To identify drivers and challenges for India respiratory inhalers market
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India respiratory inhalers market.
  • To identify and analyze the profile of leading players operating in India respiratory inhalers market.
  • To identify key sustainable strategies adopted by market players in India respiratory inhalers market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturing across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturing who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturing, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India respiratory inhalers market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Respiratory inhaler manufacturing companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to respiratory inhalers

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturing, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India respiratory inhalers market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         India Respiratory Inhalers Market, By Product Type:

    • Dry Powder Inhaler
    • Metered Dose Inhaler
    • Others
  • India Respiratory Inhalers Market, By Technology:
    • Manually Operated Inhalers
    • Digitally Operated Inhalers
  • India Respiratory Inhalers Market, By Disease Indication:
    • COPD
    • Asthma
    • Pulmonary Atrial Hypertension
    • Others
  • India Respiratory Inhalers Market, By Distribution Channel:
    • Online
    • Offline
  • India Respiratory Inhalers Market, By End User:
    • Hospitals & Clinics
    • Homecare
    • Others
  • India Respiratory Inhalers Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India respiratory inhalers market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India respiratory inhalers market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on India Respiratory Inhalers Market

4.    Executive Summary

5.    Voice of Customer

6.    India Respiratory Inhalers Market Outlook

6.1.  Market Size & Forecast

6.1.1. By Value & Volume

6.2.  Market Share & Forecast

6.2.1. By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Others)

6.2.2. By Technology (Manually Operated Inhalers v/s Digitally Operated Inhalers)

6.2.3. By Disease Indication (COPD, Asthma, Pulmonary Atrial Hypertension, Others)

6.2.4. By Distribution Channel (Online v/s Offline)

6.2.5. By End User (Hospitals & Clinics, Homecare, Others)

6.2.6. By Region

6.2.7. By Company (FY2021)

6.3.  Product Market Map

7.    India Manually Operated Inhalers Market Outlook

7.1.  Market Size & Forecast          

7.1.1. By Value & Volume

7.2.  Market Share & Forecast

7.2.1. By Product Type

7.2.2. By Disease Indication

7.2.3. By Distribution Channel

7.2.4. By End User

8.    India Digitally Operated Inhalers Market Outlook

8.1.  Market Size & Forecast          

8.1.1. By Value & Volume

8.2.  Market Share & Forecast

8.2.1. By Product Type

8.2.2. By Disease Indication

8.2.3. By Distribution Channel

8.2.4. By End User

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  Pricing Analysis

13.  Import-Export Analysis

14.  India Economic Profile

15.  Competitive Landscape

15.1.              Company Profiles

15.1.1.1.      Philips India Limited

15.1.1.2.      Cipla Limited

15.1.1.3.      Teva API India Limited

15.1.1.4.      Astra Zeneca Pharma India Limited

15.1.1.5.      GlaxoSmithKline Pharmaceuticals Ltd

15.1.1.6.      Omron Healthcare India Pvt. Ltd.

15.1.1.7.      Novartis India Ltd.

15.1.1.8.      3M India ltd

15.1.1.9.      Glenmark Pharmaceuticals Limited

15.1.1.10.    Merck India

16.  Strategic Recommendations

 17. About us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]